9065SP |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Serum/Plasma |
9065TI |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Tissue |
9101SP |
Acepromazine Screen, Serum/Plasma |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9109SP |
Atropine Screen, Serum/Plasma |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9132SP |
Oxycodone Screen, Serum/Plasma |
9136SP |
Chlorpromazine Screen, Serum/Plasma |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9159SP |
Disopyramide Screen, Serum/Plasma |
9163SP |
Doxylamine Screen, Serum/Plasma |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9176SP |
Fentanyl and Metabolite Screen, Serum/Plasma |
9176TI |
Fentanyl and Metabolite Screen, Tissue |
9179SP |
Fluoxetine and Metabolite Screen, Serum/Plasma |
9182SP |
Haloperidol Screen, Serum/Plasma |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9196SP |
Meclizine Screen, Serum/Plasma |
9200SP |
Mepivacaine Screen, Serum/Plasma |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9211SP |
Mexiletine Screen, Serum/Plasma |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9247SP |
Propranolol Screen, Serum/Plasma |
9248SP |
Pseudoephedrine Screen, Serum/Plasma |
9253SP |
Propofol Screen, Serum/Plasma |
9261SP |
Scopolamine Screen, Serum/Plasma |
9276SP |
Thiothixene (Cis Isomer) Screen, Serum/Plasma |
9288SP |
Tramadol and Metabolite Screen, Serum/Plasma |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9308SP |
Amantadine Screen, Serum/Plasma |
9317SP |
Lidocaine and Metabolite (MEGX) Screen, Serum/Plasma |
9324SP |
Methadone Screen, Serum/Plasma |
9326SP |
Gamma-Hydroxybutyric Acid Screen, Serum/Plasma |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9332SP |
Hydrocodone Screen, Serum/Plasma |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9343SP |
Heroin Screen, Serum/Plasma |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9356SP |
Cannabinoids Screen, Serum/Plasma |
9401SP |
Chloral Hydrate Screen, Serum/Plasma |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9419SP |
Thiopental and Metabolite Screen, Serum/Plasma |
9427SP |
Thioridazine and Metabolite Screen, Serum/Plasma |
9431SP |
Antidepressants Screen, Serum/Plasma |
9432SP |
Amitriptyline and Metabolite Screen, Serum/Plasma |
9434SP |
Imipramine and Metabolite Screen, Serum/Plasma |
9436SP |
Protriptyline Screen, Serum/Plasma |
9437SP |
Clomipramine and Metabolite Screen, Serum/Plasma |
9440SP |
Meperidine and Metabolite Screen, Serum/Plasma |
9441SP |
Pentazocine Screen, Serum/Plasma |
9443SP |
Glutethimide Screen, Serum/Plasma |
9522SP |
Methamphetamine and Amphetamine Screen, Serum/Plasma |